⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 22 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 22 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT January 10, 2024

Fostimon 150 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung 150 IE (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung)

📷 PubChem CID 73759969 · Source
Fostimon 150 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung 150 IE (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung)
📷 PubChem CID 73759969 · Source
Fostimon 150 IU powder and solvent for injection solution is temporarily unavailable. No packs are currently in stock. Resupply is expected on 10 January 2039.
🗄
Archived (older alert)
This alert was reported 931 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
72 days in total
May 18, 2026 July 29, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Fostimon is a medicine used in injections. It helps with fertility treatments.

What's happening? The medicine is not available right now. Supplies may return in 2039.

Does this affect me? If you use Fostimon, you may not be able to get it.

What should I do? Talk to your pharmacist or doctor about other options.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

ATC: G03GA04 · Reason: Vorübergehende Einstellung des Inverkehrbringens · Marketing authorisation holder: IBSA Farmaceutici Italia S.r.l., Via Martiri Di Cefalonia 2, 26900 Lodi, Italien · Affected packs: 1 Stück Schachtel, Durchstechflasche [Nicht verfügbar, since 2024-01-10, resupply 2039-01-10] · 5 Stück Schachtel, Durchstechflasche [Nicht verfügbar, since 2024-04-10, resupply 2039-01-10] · 10 Stück Schachtel, Durchstechflasche [Nicht verfügbar, since 2024-01-10, resupply 2039-01-10]

First published
January 10, 2024
Last refreshed by us
2 months ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this medicine shortage alert about?
Fostimon 150 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung 150 IE (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung). Fostimon 150 IU powder and solvent for injection solution is temporarily unavailable. No packs are currently in stock. Resupply is expected on 10 January 2039.
When was this alert issued?
This alert was issued on January 10, 2024 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.